METROPOLITAN LIFE INSURANCE CO/NY - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,722
-27.5%
3,901
+9.7%
0.00%
-50.0%
Q2 2023$36,876
+60.8%
3,556
+25.5%
0.00%
+100.0%
Q1 2023$22,927
-66.7%
2,834
-35.2%
0.00%
-66.7%
Q4 2022$68,891
+20.6%
4,374
+20.5%
0.00%0.0%
Q3 2022$57,120
+12.7%
3,6290.0%0.00%
+50.0%
Q2 2022$50,661
-1.9%
3,629
+21.1%
0.00%0.0%
Q1 2022$51,651
-72.0%
2,996
-76.4%
0.00%
-33.3%
Q4 2021$184,600
-19.2%
12,6960.0%0.00%0.0%
Q3 2021$228,528
+2.5%
12,6960.0%0.00%0.0%
Q2 2021$222,942
+149.8%
12,696
+5.1%
0.00%
+50.0%
Q4 2018$89,256
-44.4%
12,078
+9.2%
0.00%
-33.3%
Q3 2018$160,533
-99.9%
11,0560.0%0.00%
-25.0%
Q2 2018$220,788,000
+68.8%
11,056
+48.1%
0.00%
+100.0%
Q1 2018$130,821,000
+70998.4%
7,4670.0%0.00%0.0%
Q4 2017$184,000
-50.4%
7,467
-48.1%
0.00%0.0%
Q3 2017$371,000
-4.9%
14,3740.0%0.00%
-33.3%
Q2 2017$390,000
+62.5%
14,374
+78.3%
0.00%
+50.0%
Q1 2017$240,000
+9.6%
8,0610.0%0.00%0.0%
Q4 2016$219,000
+6.3%
8,0610.0%0.00%0.0%
Q3 2016$206,0008,0610.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Endurant Capital Management LP 1,769,785$1,911,0000.69%
Telemetry Investments, L.L.C. 214,593$232,0000.67%
Aisling Capital Management LP 634,455$685,0000.36%
Broadfin Capital, LLC 1,620,000$1,750,0000.32%
MFN Partners Management, LP 1,500,000$1,620,0000.24%
Sofinnova Investments, Inc. 1,911,573$2,064,0000.19%
Rock Springs Capital Management LP 2,974,754$3,213,0000.13%
Alambic Investment Management, L.P. 150,636$163,0000.12%
Cormorant Asset Management, LP 250,000$270,0000.02%
Man Group plc 3,734,793$4,034,0000.02%
View complete list of ACLARIS THERAPEUTICS INC shareholders